Although a decreasing trend in clinical practice patterns regarding perioperative SGLT-2i discontinuation were observed following the guideline update (data not shown), the absence of DKA cases after 2021 suggests increased clinical awareness and caution regarding the risk of SGLT-2i–associated DKA in the perioperative setting.
← all excerpts
The Protective Effects of SGLT-2 Inhibitors Against Postoperative Acute Kidney Injury in Type 2 Diabetes.
1
—
—